Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC | Zendy

Roy S. Herbst | Zendy; Giuseppe Giaccone | Zendy; Filippo de Marinis | Zendy; Niels Reinmuth | Zendy; A. Vergnenègre | Zendy; Carlos H. Barrios | Zendy; Masahiro Morise | Zendy; Enriqueta Felip | Zendy; Zoran Andrić | Zendy; Sarayut Lucien Geater | Zendy; Mustafa Özgüroğlu | Zendy; Wei Zou | Zendy; Alan Sandler | Zendy; Ida Enquist | Zendy; Kimberly M. Komatsubara | Zendy; Yu Deng | Zendy; Hiroshi Kuriki | Zendy; Xiaohui Wen | Zendy; Mark L. McCleland | Zendy; Simonetta Mocci | Zendy; Jacek Jassem | Zendy; David R. Spigel | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC

Author(s) -

Roy S. Herbst,

Giuseppe Giaccone,

Filippo de Marinis,

Niels Reinmuth,

A. Vergnenègre,

Carlos H. Barrios,

Masahiro Morise,

Enriqueta Felip,

Zoran Andrić,

Sarayut Lucien Geater,

Mustafa Özgüroğlu,

Wei Zou,

Alan Sandler,

Ida Enquist,

Kimberly M. Komatsubara,

Yu Deng,

Hiroshi Kuriki,

Xiaohui Wen,

Mark L. McCleland,

Simonetta Mocci,

Jacek Jassem,

David R. Spigel

Publication year - 2020

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1917346

Subject(s) - atezolizumab , medicine , oncology , lung cancer , hazard ratio , chemotherapy , population , immunohistochemistry , pembrolizumab , cancer , immunotherapy , confidence interval , environmental health

The efficacy and safety of the anti-programmed death ligand 1 (PD-L1) monoclonal antibody atezolizumab, as compared with those of platinum-based chemotherapy, as first-line treatment for patients with metastatic non-small-cell lung cancer (NSCLC) with PD-L1 expression are not known.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research